Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1995 1
1996 4
1997 2
1998 6
1999 7
2000 7
2001 4
2002 5
2003 6
2004 4
2005 10
2006 9
2007 11
2008 8
2010 6
2011 4
2012 5
2013 11
2014 9
2015 6
2016 3
2017 7
2018 4
2019 4
2020 6
2021 10
2022 13
2023 20

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial.
Diaz-Manera J, Kishnani PS, Kushlaf H, Ladha S, Mozaffar T, Straub V, Toscano A, van der Ploeg AT, Berger KI, Clemens PR, Chien YH, Day JW, Illarioshkin S, Roberts M, Attarian S, Borges JL, Bouhour F, Choi YC, Erdem-Ozdamar S, Goker-Alpan O, Kostera-Pruszczyk A, Haack KA, Hug C, Huynh-Ba O, Johnson J, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Diaz-Manera J, et al. Lancet Neurol. 2021 Dec;20(12):1012-1026. doi: 10.1016/S1474-4422(21)00241-6. Lancet Neurol. 2021. PMID: 34800399 Clinical Trial.
Efficacy and Safety of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease After 97 Weeks: A Phase 3 Randomized Clinical Trial.
Kishnani PS, Diaz-Manera J, Toscano A, Clemens PR, Ladha S, Berger KI, Kushlaf H, Straub V, Carvalho G, Mozaffar T, Roberts M, Attarian S, Chien YH, Choi YC, Day JW, Erdem-Ozdamar S, Illarioshkin S, Goker-Alpan O, Kostera-Pruszczyk A, van der Ploeg AT, An Haack K, Huynh-Ba O, Tammireddy S, Thibault N, Zhou T, Dimachkie MM, Schoser B; COMET Investigator Group. Kishnani PS, et al. JAMA Neurol. 2023 Jun 1;80(6):558-567. doi: 10.1001/jamaneurol.2023.0552. JAMA Neurol. 2023. PMID: 37036722 Free PMC article. Clinical Trial.
Creatine for treating muscle disorders.
Kley RA, Tarnopolsky MA, Vorgerd M. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD004760. doi: 10.1002/14651858.CD004760.pub4. Cochrane Database Syst Rev. 2013. PMID: 23740606 Free PMC article. Review.
Creatine for treating muscle disorders.
Kley RA, Tarnopolsky MA, Vorgerd M. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD004760. doi: 10.1002/14651858.CD004760.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328269 Updated. Review.
Progesterone: A Neuroprotective Steroid of the Intestine.
Stegemann LN, Neufeld PM, Hecking I, Vorgerd M, Matschke V, Stahlke S, Theiss C. Stegemann LN, et al. Among authors: vorgerd m. Cells. 2023 Apr 21;12(8):1206. doi: 10.3390/cells12081206. Cells. 2023. PMID: 37190115 Free PMC article.
Bi-allelic truncating mutations in VWA1 cause neuromyopathy.
Deschauer M, Hengel H, Rupprich K, Kreiß M, Schlotter-Weigel B, Grimmel M, Admard J, Schneider I, Alhaddad B, Gazou A, Sturm M, Vorgerd M, Balousha G, Balousha O, Falna M, Kirschke JS, Kornblum C, Jordan B, Kraya T, Strom TM, Weis J, Schöls L, Schara U, Zierz S, Riess O, Meitinger T, Haack TB. Deschauer M, et al. Among authors: vorgerd m. Brain. 2021 Mar 3;144(2):574-583. doi: 10.1093/brain/awaa418. Brain. 2021. PMID: 33459760
Creatine for treating muscle disorders.
Kley RA, Vorgerd M, Tarnopolsky MA. Kley RA, et al. Among authors: vorgerd m. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004760. doi: 10.1002/14651858.CD004760.pub2. Cochrane Database Syst Rev. 2007. PMID: 17253521 Updated. Review.
Carbohydrate oxidation disorders of skeletal muscle.
Vorgerd M, Zange J. Vorgerd M, et al. Curr Opin Clin Nutr Metab Care. 2002 Nov;5(6):611-7. doi: 10.1097/00075197-200211000-00003. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12394636 Review.
178 results